Stocks Consumer discretionary EVH
NYSE · Consumer discretionaryEvolent Health, Inc. (EVH)
Evolent Health, Inc. brought in $2.3B of revenue over the twelve months to September 30, 2026, up 14.1% from a year earlier. It posted a net loss of $507.7M. At September 30, 2026 it held $148.3M in cash against $969.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Evolent Health, Inc.
- Net worth
- Evolent Health, Inc. has a market value (market cap) of $542.7M at the latest share price, and shareholders' equity of $372.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.9B (-26.6% year on year), with a net loss of $534.5M. Over the 12 months to September 30, 2026: revenue $2.3B, net loss $507.7M.
- Cash flow
- In fiscal 2025 operations brought in $38.8M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Evolent Health, Inc.'s next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Evolent Health, Inc. does
Evolent Health, Inc. is registered with the SEC under industry code SIC 8741 (Services-Management Services). Its shares trade on NYSE under the ticker EVH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.9B | -$534.5M | -$5.07 | n/a |
| 2024 | $2.6B | -$61.6M | -$0.81 | n/a |
| 2023 | $2B | -$113M | -$1.28 | n/a |
| 2022 | $1.4B | -$19.2M | -$0.20 | n/a |
| 2021 | $908M | -$37.6M | -$0.44 | n/a |
| 2020 | $924.6M | -$334.2M | -$3.94 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where EVH ranks in Consumer discretionary
Latest SEC filings
What Evolent Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 51% to $725.4M versus the same quarter last year; diluted EPS -$0.21 versus -$0.24.
- September 8, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 47% to $652.5M versus the same quarter last year; diluted EPS -$0.25 versus -$0.44.
- August 6, 2026
- July 17, 2026Passive stake (5% or more) SCHEDULE 13G
- June 10, 2026
- June 4, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 2.6% to $496.2M versus the same quarter last year; diluted EPS -$0.24 versus -$0.63.
- May 7, 2026
Insider trades
What the people running Evolent Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $329.5K worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 26, 2026 | McCarthy Daniel JosephPRESIDENT | Soldpre-planned (10b5-1) | 65,892 | $329.5K |
| July 1, 2026 | Shams AammaadChief Accounting Officer | Received as pay | 28,790 | - |
| July 1, 2026 | McCarthy Daniel JosephPRESIDENT | Received as pay | 302,585 | - |
| July 1, 2026 | McCarthy Daniel JosephPRESIDENT | Shares withheld for tax | 4,582 | $26.3K |
| July 1, 2026 | Blackley SethChief Executive Officer, Director | Received as pay | 446,102 | - |
| July 1, 2026 | Blackley SethChief Executive Officer, Director | Shares withheld for tax | 10,297 | $59.1K |
| July 1, 2026 | Weinberg JonathanGeneral Counsel | Received as pay | 43,055 | - |
| July 1, 2026 | Weinberg JonathanGeneral Counsel | Shares withheld for tax | 2,650 | $15.2K |
Who owns EVH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Cadian Capital Management, LP13G, passive with 2 related filers | 9.3% | May 15, 2025 |
| BlackRock Portfolio Management LLC13G, passive | 5.5% | July 17, 2026 |
| Rubicon OP GP II LP13G, passive with 5 related filers | 5.21% | November 14, 2025 |
Largest institutional holders
Insiders
14 insiders reported holding 3,613,932 shares in total, about $17.3M at the last price.
| Holder | Shares |
|---|---|
| Blackley SethChief Executive Officer, Director | 1,272,767 |
| McCarthy Daniel JosephPRESIDENT | 655,133 |
| Ramos MarioChief Financial Officer | 587,500 |
| Weinberg JonathanGeneral Counsel | 284,917 |
| Keck KimDirector | 102,597 |
| Springstubb Brendan BDirector | 99,917 |
| Shams AammaadChief Accounting Officer | 95,637 |
| Barbarosh Craig A.Director | 95,031 |
| Jelinek Richard MDirector | 77,533 |
| Glass Russell MonroeDirector | 77,347 |
Questions about EVH
What does Evolent Health, Inc. do?
Evolent Health, Inc. is a company in the Consumer discretionary sector, listed on NYSE as EVH. Its shares trade on NYSE under the ticker EVH.
What is Evolent Health, Inc.'s net worth?
Evolent Health, Inc. has a market value (market cap) of $542.7M at the latest share price, and shareholders' equity of $372.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Evolent Health, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $507.7M on revenue of $2.3B.
How much revenue does Evolent Health, Inc. make?
Over the twelve months to September 30, 2026 Evolent Health, Inc. reported revenue of $2.3B. That is 14.1% more than a year earlier.
When did Evolent Health, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Evolent Health, Inc.'s next earnings report?
Evolent Health, Inc.'s next report is expected around February 23, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare EVH with
Follow EVH
Get an email when Evolent Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Evolent Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.